about
Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-β cytostatic program and blocks the antiproliferative effect of TGF-βBroccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostateBMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivoPro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.Partners in crime: the TGFβ and MAPK pathways in cancer progression.Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer.Future opportunities for the diagnosis and treatment of prostate cancer.Phospho-specific Smad3 signaling: impact on breast oncogenesis.Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistanceGrowth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.Proteomics approaches to urologic diseases.Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival.Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse modelStroma-epithelium crosstalk in prostate cancer.Prostate cancer: the need for biomarkers and new therapeutic targets.TGF-β: duality of function between tumor prevention and carcinogenesis.Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis.Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.Steps in prostate cancer progression that lead to bone metastasisTherapeutic modulation of prostate cancer metastasis.Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.Skip Regulates TGF- β 1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells.Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells.Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
P2860
Q24339393-FAA9550A-70DE-4E73-9C3E-ADA91D305B43Q28473008-1190D801-0975-4FE8-9612-385FB6B0D635Q33295288-35CC5A49-7AA1-4E40-B769-1AA51DC39E80Q33918198-684E4C89-CB1C-4528-8786-84F8C26E4E9BQ35570431-07E6CB04-CC30-4937-86F8-7E929DEBCDDBQ35744886-24F28B0D-2CF2-4ED7-9044-9E63B232AF05Q35806990-1891F238-4F71-4988-A1AE-712FDE1034FCQ35886572-9AF5261D-6950-443C-A784-69F68529DBDAQ36116217-6E213558-B285-4F5F-8725-9C973B62C8CBQ36282200-F96D43ED-7C4B-43F0-8D28-91422C95AE06Q36390245-AB559AAB-37B6-4403-8E8D-78A60955221CQ36505667-C8192DE5-BBF3-4E79-A79F-6BA58B6FE931Q37304321-CC8D525C-9694-4F59-84F8-FC4726D986AAQ37355355-25F342E2-E9C7-4510-ADE5-78FD145AAA81Q37355741-52584BD7-E8F9-4839-B4B6-2E035C070EEBQ37476043-72411F9A-D055-4883-8CBB-F17211934F6CQ37634488-F05FBFA8-3654-4774-A9E3-165DCF6E3AA6Q37706935-94554AA1-E77C-4B15-9C49-503CC0A05E75Q37718420-6FD86AAD-46C8-4564-80E1-D508BF4110B0Q37848782-8648DA5E-2612-467A-A3D3-A2B173A6F03FQ38182140-02484CF9-3B68-497E-A1D8-9DEBB7287C8CQ38206962-3449FA80-4409-4AAB-A497-A25E62B319B3Q39139686-6729D9C3-1B63-4AC3-BAED-5EDFFFB06C7DQ39260860-45EBC178-98B5-4F05-91D8-DB6E3050C000Q40243334-3FE3D3C2-D30F-4C15-ADD5-D2A64936284BQ42206185-481DA024-2EE5-4E56-BCD3-596E446DA44AQ47269802-6A0D3564-B404-4166-85CE-D612FFFFA565
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
TGF-betal/Smad signaling in prostate cancer.
@ast
TGF-betal/Smad signaling in prostate cancer.
@en
type
label
TGF-betal/Smad signaling in prostate cancer.
@ast
TGF-betal/Smad signaling in prostate cancer.
@en
prefLabel
TGF-betal/Smad signaling in prostate cancer.
@ast
TGF-betal/Smad signaling in prostate cancer.
@en
P356
P1433
P1476
TGF-betal/Smad signaling in prostate cancer.
@en
P2093
Diana Bello-DeOcampo
Donald J Tindall
P304
P356
10.2174/1389450033491118
P577
2003-04-01T00:00:00Z